News

Law

Asset Management

Investment Banking

Wealth

Hedge Funds

People

Newsletters

Events

Lists

Morgan Stanley raises $950m for Irish drug company

Morgan Stanley has executed a second sale in four months for Elan, the Irish pharmaceuticals group run by a 21-year Merrill Lynch veteran.

Elan retained Morgan Stanley to advise it on its primary care business to US rival King Pharmaceuticals for up to $950m (€874m).

WSJ Logo